Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on June 9, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Supply of Process Analytical Technology (PAT) Rig or Equivalent Instrument

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract involves the procurement and delivery of a standalone Process Analytical Technology (PAT) Rig system, such as the GEA ConsiGma model or an equivalent instrument. This system must be capable of real-time monitoring of pharmaceutical manufacturing processes through advanced spectroscopic techniques including Near-Infrared (NIR), Raman, or Ultraviolet-Visible (UV-Vis) spectroscopy. The objective is to enhance process control and quality assurance in pharmaceutical production by integrating cutting-edge analytical technology. The solicitation is issued by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. It is a subcontract opportunity under NAICS code 334516, relating to manufacturing and supplying of specialized instrumentation. The contract was posted on June 9, 2026, with a response deadline of June 17, 2026, at 8:30 PM. Specific location details for the point of performance or contact information were not provided. This contract emphasizes timely delivery of a reliable analytical rig that meets stringent pharmaceutical standards to support regulatory and operational needs.

General Info

Procurement of standalone PAT Rig for real-time pharmaceutical process monitoring, deadline June 17, 2026.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

This scope was carved out of 75F40126Q131715.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

GEA North America LLC ConsiGma standalone Process Analytical Technology (PAT) Rig, or equivalent

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Procurement and delivery of a standalone PAT Rig system, such as the GEA ConsiGma model or equivalent, capable of real-time monitoring of pharmaceutical processes using NIR, Raman, or UV-Vis spectroscopy.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS